Richard Aguilar - Aug 25, 2021 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role
Chief Clinical Officer
Signature
/s/ David Armstrong, Attorney-in-Fact
Stock symbol
CANO
Transactions as of
Aug 25, 2021
Transactions value $
$15,652,981
Form type
4
Date filed
8/31/2021, 05:53 PM
Previous filing
Jun 14, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Purchase $613K +51.4K $11.93* 51.4K Aug 25, 2021 Direct F1
transaction CANO Class A Common Stock Purchase $863K +72K +140.12% $11.99* 123K Aug 26, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CANO Warrants to purchase Class A Common Stock Purchase $29.4K +8.12K $3.62* 8.12K Aug 25, 2021 Class A Common Stock 8.12K $11.50 Direct F3
transaction CANO Warrants to purchase Class A Common Stock Purchase $147K +38.6K +475.18% $3.81* 46.7K Aug 26, 2021 Class A Common Stock 38.6K $11.50 Direct F4
transaction CANO Class B Common Stock Purchase $7M +651K $10.75* 651K Aug 30, 2021 Class A Common Stock 651K Direct F5, F7
transaction CANO PCIH Common Units Purchase $7M +651K $10.75* 651K Aug 30, 2021 Class A Common Stock 651K Direct F5, F7
holding CANO Class B Common Stock 10.9M Aug 25, 2021 Class A Common Stock 10.9M See Footnote F5, F6
holding CANO PCIH Common Units 10.9M Aug 25, 2021 Class A Common Stock 10.9M See Footnote F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.59 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.47 to $12.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.55 to $3.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.
F5 Common limited liability company units of Primary Care (ITC) Intermediate Holdings, LLC ("PCIH Common Units"), together with an equal number of shares of the Issuer's Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), are exchangeable for either cash or shares of Class A Common Stock on a one-for-one basis. The PCIH Common Units have no expiration date.
F6 The Class B Common Stock and PCIH Common Units are owned indirectly by the reporting person through Aguilar Borrower Holdings, LLC. The reporting person has sole voting and dispositive power with respect to all of the securities held by Aguilar Borrower Holdings, LLC and therefore is the beneficial owner of these securities.
F7 These securities were purchased from an existing stockholder of the Issuer in a private transaction. The combined price per each one share of Class B Common Stock and one PCIH Common Unit was negotiated on an arm's-length basis and determined based on the opening price of Cano's Class A Common Stock on August 16, 2021.